Sodium–glucose cotransporter-2 inhibitors improve cardiovascular outcomes post-acute coronary syndrome complicated by acute heart failure

Sodium–glucose cotransporter-2 inhibitors improve cardiovascular outcomes post-acute coronary syndrome complicated by acute heart failure

BackgroundAcute coronary syndrome (ACS) remains a risk factor for heart failure (HF). Therefore, we aimed to assess the cardioprotective role of sodium–glucose cotransporter-2 (SGLT2) inhibitors post-ACS in patients with acute HF (AHF) and diabetes.MethodsWe conducted a retrospective observational c...

Full description

Bibliographic Details
Main Authors: Alaa Rahhal, Tahseen Hamamyh, Ammar Chapra, Khaled J. Zaza, Mostafa Najim, Mohammad Hemadneh, Hazem Faraj, Wael Kanjo, Ahmed Yasin, Haneen Toba, Wafa Mohammed, Mohammad Khair Hamad, Nawras Al-Tikrety, Mhd Baraa Habib, Ahmed Awaisu, Ahmed Mahfouz, Sumaya Alyafei, Abdul Rahman Arabi, Ashfaq Patel, Mohammed Al-Hijji
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-05-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
acute coronary syndrome
heart failure
sodium–glucose cotransporter-2 (SGLT-2) inhibitors
HF hospitalization
cardioprotection
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2024.1383669/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2024.1383669/full

Similar Items